Previous close | 3.0000 |
Open | 3.0200 |
Bid | 2.9800 x N/A |
Ask | 3.1800 x N/A |
Day's range | 3.0200 - 3.0200 |
52-week range | 2.0600 - 11.6300 |
Volume | |
Avg. volume | 0 |
Market cap | 21.832M |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Minerva Neurosciences (NERV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
In this piece, we will take a look at the 12 best performing biotechnology stocks in 2023. If you want to skip our introduction to the biotechnology industry and some top players, then check out 5 Best Performing Biotech Stocks in 2023. Biotechnology is one of the hottest industries these days and one that has […]